FuturHealth files Chapter 11 in Delaware

FuturHealth, Inc., a San Diego direct-to-consumer weight-loss telehealth company, filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the District of Delaware on November 1, 2026, case 26-11748. Bankruptcy Observer and PACER-style docket republications on BKAlerts and Inforuptcy show the petition as voluntary, with debtor counsel Ice Miller LLP and a San Diego mailing address on West Washington Street.

What the petition and first-day papers show

The petition ranges put assets and liabilities each at $10 million to $50 million. ElevenFlo’s case summary, which it says draws from court records, lists funded debt of about $2.77 million as of the petition date across three identified instruments. We have not independently opened the CEO declaration PDF on PACER.

First-day papers on the aggregators include a motion to approve debtor-in-possession financing (Dkt. 9), the supporting Richard Klein financing declaration (Dkt. 10), and the Declaration of Jon Hambidge in support of the petition and first-day motions (Dkt. 11). Companion relief includes a motion to pay employee wages (Dkt. 8) and a motion to pay certain prepetition taxes and fees (Dkt. 7). An application to appoint Stretto as claims and noticing agent also appears on the opening docket.

Hearing and what the company sells

A notice of agenda for matters scheduled for hearing (Dkt. 16) sets a first-day hearing for November 3, 2026, at 11:30 a.m. ET in Wilmington, Delaware, according to ElevenFlo and the docket text.

FuturHealth’s own site frames the business as clinician-guided weight loss that pairs medication with nutrition and fitness support. The how-it-works and home pages list Foundayo (labeled orforglipron), the Wegovy pen and Wegovy pill, and the Zepbound KwikPen, and they market telehealth dietitians and clinician care around those prescriptions. We did not rely on third-party profiles that discuss compounded semaglutide; the company pages we loaded emphasize FDA-approved branded options.

What is not known

• The full text of the Hambidge first-day declaration and the DIP term sheet (PACER/RECAP copies were not reachable for this report).
• Whether a Stretto public case page is live yet for creditors.
• How the Chapter 11 case will affect ongoing prescriptions, refunds or memberships — none of the loaded pages settle that for patients.

What to watch

Interim DIP and wage/tax orders from the November 3 hearing; any customer-notice protocol under the redaction motion; and whether schedules and the claims bar date clarify the funded-debt picture beyond the ElevenFlo summary figure.